Download full-text


Available from: John J Oppenheimer, Mar 14, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Practice parameters and guidelines shape and influence the method and manner in which medicine is practiced. With more than 121 scales and methods of assessing and rating evidence, a comparison of practice parameters can appear daunting. An evaluation of the evidence engenders a sense of the evolution of a specialty and a roadmap for the future. Objective: To assess the level of evidence underlying recommendations in allergy-immunology (AI) practice parameters. Methods: We analyzed the practice parameters that guide AI (n = 15), otolaryngology (n = 8), pediatrics (n = 13), and internal medicine (n = 10) as they appeared on August 30, 2012. Strength of recommendation data was compared after making adjustments for differences in rating scales. Results: The strength of recommendation calculated from strong to weak for the AI practice parameters using a standardized format yielded the following grades: A in 195 (13.9%), B in 342 (24.4%), C in 606 (43.2%), D in 231 (16.4%), and E in 29 (2.1%). Controlled trial-based evidence (A and B) demonstrated considerable variability among individual AI practice parameters (range, 1.3%-100%). Evidence from controlled trials was lower in the subspecialty fields (38.3% in AI and 38.2% in otolaryngology) compared with the primary care fields (55.6% in pediatrics and 86.1% in internal medicine). Conclusion: Considerable variability exists in the strength of recommendations within the AI practice parameters. The guidelines created by the primary care fields rest on a larger base of evidence collected from controlled trials. These findings likely reflect the adopted approach of making recommendations for less well-studied conditions and practices in AI to assist practitioners and patients and at the same time highlight the myriad opportunities for future research.
    Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, & Immunology 05/2014; 113(2). DOI:10.1016/j.anai.2014.04.019 · 2.75 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Exposure to indoor pollutants and allergens has been speculated to cause asthma symptoms and exacerbations and influence the risk of developing asthma. The aim of this article is to review the medical literature regarding the role of the indoor environment on inner-city childhood asthma.
    Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand 06/2014; 32(2):103-110. · 1.26 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In the modern era, the prevalence of asthma and allergies are increasing. It has been speculated that environmental exposures are contributing to this rise. Several studies demonstrate that common indoor allergen exposures exacerbate asthma. Minimizing exposure to allergens and remediating the environment play a critical role in the treatment of asthma and allergies. The most effective environmental control measures are tailored multifaceted interventions which include education, thorough cleaning, using high-efficiency particulate air (HEPA) filters, integrated pest management, and maintenance of these practices.
    Current Allergy and Asthma Reports 03/2014; 14(3):419. DOI:10.1007/s11882-014-0419-7 · 2.45 Impact Factor